| 000 | 01713 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512231556.0 | ||
| 264 | 0 | _c19821203 | |
| 008 | 198212s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19821015)50:8<1472::aid-cncr2820500805>3.0.co;2-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHays, D M | |
| 245 | 0 | 0 |
_aBladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy. _h[electronic resource] |
| 260 |
_bCancer _cOct 1982 |
||
| 300 |
_a1472-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDactinomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xsurgery |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xsurgery |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xsurgery |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aRaney, R B | |
| 700 | 1 | _aLawrence, W | |
| 700 | 1 | _aSoule, E H | |
| 700 | 1 | _aGehan, E A | |
| 700 | 1 | _aTefft, M | |
| 773 | 0 |
_tCancer _gvol. 50 _gno. 8 _gp. 1472-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19821015)50:8<1472::aid-cncr2820500805>3.0.co;2-y _zAvailable from publisher's website |
| 999 |
_c6749060 _d6749060 |
||